Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (221-230 of 375) with videos related to

Pageof 38
Sort By:
Future Oncology (London, England)|May 13, 2026
Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journeyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.
Reproductive Biomedicine Online|March 28, 2019
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patientsMatteo Lambertini, Massimo Di Maio, Francesca Poggio, et al.
Critical Reviews in Oncology/Hematology|May 30, 2021
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysisMarco Tagliamento, Elisa Agostinetto, Marco Bruzzone, et al.
Current Treatment Options in Oncology|March 13, 2024
Ovarian Suppression: Early Menopause and Late EffectsChiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2023
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysisAndrea Boutros, Enrica Teresa Tanda, Elena Croce, et al.
Breast Cancer Research and Treatment|September 25, 2016
Treatment with aromatase inhibitors and markers of cardiovascular diseaseEva Blondeaux, Debora Musio, Paolo Bruzzi, et al.
Frontiers in Oncology|June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast CancerEva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.
Breast (Edinburgh, Scotland)|March 30, 2025
Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European surveyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
Pageof 38

Showing results (221-230 of 375) with videos related to

Sort By:
Pageof 38
Future Oncology (London, England)|May 13, 2026
Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journeyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.
Reproductive Biomedicine Online|March 28, 2019
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patientsMatteo Lambertini, Massimo Di Maio, Francesca Poggio, et al.
Critical Reviews in Oncology/Hematology|May 30, 2021
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysisMarco Tagliamento, Elisa Agostinetto, Marco Bruzzone, et al.
Current Treatment Options in Oncology|March 13, 2024
Ovarian Suppression: Early Menopause and Late EffectsChiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2023
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysisAndrea Boutros, Enrica Teresa Tanda, Elena Croce, et al.
Breast Cancer Research and Treatment|September 25, 2016
Treatment with aromatase inhibitors and markers of cardiovascular diseaseEva Blondeaux, Debora Musio, Paolo Bruzzi, et al.
Frontiers in Oncology|June 21, 2021
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast CancerEva Blondeaux, Claudia Massarotti, Valeria Fontana, et al.
Breast (Edinburgh, Scotland)|March 30, 2025
Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European surveyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
Pageof 38